As for IL‐25, administration of recombinant IL‐33 has been demonstrated to generate resistance to HD Tm in normally susceptible AKR mice, and an increase in Il33 transcription in the caecum (20‐fold over naïve at d3) has been measured in resistant BALB/c mice [94]. The gene discussed is IL33; the disease is Huntington disease.